Drug Trial Radar · NCT04409509
Treatment With CSL312 in Adults With Coronavirus Disease 2019 (COVID-19)
Last checked: Nov 20, 2026Latest source record: Jan 24, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
124
Actual
Start
Jul 1, 2020
Primary completion
Jan 12, 2021
Study completion Jan 12, 2021
Sponsor
- Lead sponsor
- CSL BehringIndustry
- Sponsor type
- Industry
- First posted
- Jun 1, 2020
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a prospective, phase 2, multicenter, randomized, double blind, placebo controlled, parallel group study to assess the safety and efficacy of CSL312 administered intravenously, in combination with standard of care (SOC) treatment, in patients with Coronavirus disease 2019 (COVID 19)
Conditions
- Coronavirus Disease 2019 (COVID-19)
Interventions
Garadacimab, Factor XIIa Antagonist Monoclonal AntibodyBiological
Garadacimab, Factor XIIa Antagonist Monoclonal Antibody administered intravenously
PlaceboDrug
CSL312 diluent administered intravenously
Primary outcomes
What the sponsor says the trial is designed to measure.
- The Percent of Participants With Tracheal Intubation or Death Prior to Tracheal IntubationTime frame: From randomization to Day 28
Locations
14 sites in 1 country. Site status is shown where the registry gives one.
Nova Clinical Research, LLC
Bradenton, Florida
Theia Clinical Research, LLC
St. Petersburg, Florida
MercyOne North Iowa Medical Center
Mason City, Iowa
Northeast Iowa Medical Education Foundation
Waterloo, Iowa
Lahey Hospital and Medical Center
Burlington, Massachusetts
University of Mississippi Medical Center
Jackson, Mississippi
Holy Name Hospital
Teaneck, New Jersey
Inspira Health Center Vineland
Vineland, New Jersey
Sisters of Charity Hospital/ St. Joseph's Campus
Buffalo, New York
Carolina Institute for Clinical Research
Fayetteville, North Carolina
Monument Health Clinical Research
Rapid City, South Dakota
PharmaTex Research
Amarillo, Texas
UT Health Science Center, McGovern Medical School
Houston, Texas
Inova Alexandria Hospital
Alexandria, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.